Esperion Therapeutics | ESPR - Ordinary Share Capital

Stock Price
3.49
Daily Change
0.10 2.80%
Monthly
-1.83%
Yearly
85.37%
Q1 Forecast
2.70

Esperion Therapeutics reported $112K in Ordinary Share Capital for its fiscal quarter ending in September of 2023.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alnylam Pharmaceuticals USD 131.79M 130.49M Sep/2025
Alterity Therapeutics Limited AUD 213.97M 144.39K Jun/2023
Amarin USD 20.8M 28K Sep/2025
Amgen USD 539M 1000K Dec/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
Cipla INR 807.77M 807.43M Sep/2025
CSL USD 576M 19M Dec/2024
Cytokinetics USD 122.12M 2.52M Sep/2025
Daiichi Sankyo JPY 1.85B 9K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Esperion Therapeutics USD 112K 11K Sep/2023
Geron USD 638.02M 637.38M Sep/2025
Grifols EUR 679.73M 0 Sep/2025
Halozyme Therapeutics USD 117.52M 98K Sep/2025
Heron Therapeutics USD 1.52M 14K Sep/2024
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Moderna USD 391M 2M Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Pfizer USD 5.69B 1000K Sep/2025
PTC Therapeutics USD 79.93M 554K Sep/2025
Puma Biotechnology USD 5K 0 Jun/2024
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Sarepta Therapeutics USD 104.77M 7.06M Sep/2025
United Therapeutics USD 42.9M 42.1M Sep/2025
Vanda Pharmaceuticals USD 58K 0 Dec/2024